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The retinoblastoma protein-associated cell cycle arrest
in S-phase under moderate hypoxia is disrupted in cells
expressing HPV18 E7 oncoprotein
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Summary We have studied the role of the oxygen-dependent pyrimidine metabolism in the regulation of cell cycle progression under
moderate hypoxia in human cell lines containing functional (T-47D) or non-functional (NHIK 3025, SAOS-2) retinoblastoma gene product
(pRB). Under aerobic conditions, pRB exerts its growth-regulatory effects during early G, phase of the cell cycle, when all pRB present has
been assumed to be in the underphosphorylated form and bound in the nucleus. We demonstrate that pRB is dephosphorylated and re-bound
in the nucleus in approximately 90% of T-47D cells located in S and G2 phases under moderately hypoxic conditions. Under these conditions,
no T-47D cells entered S-phase, and no progression through S-phase was observed. Progression of cells through G2 and mitosis seems
independent of theirfunctional pRB status. The p21 WAF1/CIP1 protein level was significantly reduced by moderate hypoxia in p53-deficient T-47D
cells, whereas p16INK4a was not expressed in these cells, suggesting that the hypoxia-induced cell cycle arrest is independent of these cyclin-
dependent kinase inhibitors. The addition of pyrimidine deoxynucleosides did not release T-47D cells, containing mainly underphosphorylated
pRB, from the cell cycle arrest induced by moderate hypoxia. However, NHIK 3025 cells, in which pRB is abrogated by expression of the
HPV18 E7 oncoprotein, and SAOS-2 cells, which lack pRB expression, continued cell cycle progression under moderate hypoxia provided
that excess pyrimidine deoxynucleosides were present. NHIK 3025 cells express high levels of p16INK4a under both aerobic and moderately
hypoxic conditions, suggesting that the inhibitory function of p1 6INK4a would not be manifested in such pRB-deficient cells. Thus, pRB, a key
member of the cell cycle checkpoint network, seems to play a major role by inducing growth arrest under moderate hypoxia, and it gradually
overrides hypoxia-induced suppression of pyrimidine metabolism in the regulation of progression through S-phase under such conditions.
Keywords: hypoxia; cell cycle; retinoblastoma protein; cell cycle arrest; cell cycle regulation; pyrimidine de novo synthesis; DNA synthesis;
HPV18 E7 protein; human papillomavirus 18
Limitations in oxygen supply because of defective or insufficient
tissue vasculature results in hypoxia. It is generally accepted that
oxygen deficiency is a common occurrence in many human solid
tumours, and that hypoxic cells may contribute to the observed
resistance of solid tumours to radiation and chemotherapeutic
agents (Hockel et al, 1993; Teicher, 1994).
To maintain cellular homeostasis under hypoxic stress, cells
respond by inducing cell cycle arrest (Koch et al, 1973; Loffler et
al, 1978; Amellem and Pettersen, 199la), apoptosis (Graeber et al,
1996; Amellem et al, 1997), reducing energy-demanding protein
synthesis, but increasing protein degradation (Pettersen et al, 1986;
Amellem and Pettersen, 1991b). Furthermore, they induce several
stress-related gene products (Sciandra et al, 1984; Anderson and
Farkas, 1988; Heacock and Sutherland, 1990; Price and
Calderwood, 1992; Shi et al, 1993), all ofwhich may serve a time-
limited role in protecting cells from the lethal effects of hypoxia.
Cells in the G, phase have developed such protective properties
(Merz and Schneider, 1983; Spiro et al, 1984; Amellem and
Pettersen, 1991a). Recent studies have indicated that the tumour
suppressor proteins, p53 and pRB, play important roles in the
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maintenance ofcellularhomeostasis underand afterhypoxic stress
(Graeber et al, 1996; Amellem et al, 1996, 1997).
The product of the retinoblastoma gene, pRB, is a nuclear
phosphoprotein with tumour-suppressing activities that is normally
thought to function in transcriptional control of the cell cycle
(reviewed by Weinberg, 1995). The growth suppressive activity of
pRB is controlled at the level ofphosphorylation (Chen et al, 1989;
DeCaprio et al, 1989; Mihara et al, 1989), whereas the different
pRB-kinase complexes are controlled by two families of cyclin-
dependent kinase (cdk) inhibitory proteins. The p16 family inhibits
the formation of cyclin D-dependent kinase complexes, whereas
p2lWAF/CIPI and p27KIP1 are more broadly acting kinase inhibitors
(reviewed by Sherr and Roberts, 1995). The amount of pRB
protein increases in proportion with cell age throughout the cell
cycle (Stokke et al, 1993). The underphosphorylated form of
pRB, which is found in early G,, is functionally active. pRB is
phosphorylated 6-7 h before the G,/S-border and then throughout
S and G2 phases and thereby loses its growth suppressive effect
(reviewed by Sherr, 1994). Dephosphorylation ofpRB starts in late
stages ofmitosis (Ludlow et al, 1993a). pRB may exert its growth-
suppressive properties by interaction with transcription factors of
the E2F, family (Bagchi et al, 1991; Chellappan et al, 1991). It is
believed that phosphorylation of pRB in GI disrupts complex
formation with E2F, allowing expression of E2F-regulated genes
required for progression into S-phase and enzymes essential for
DNA synthesis (Lam and La Thangue, 1994). In addition, pRB has
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recently been shown to be a more global repressor of genes by
negatively regulating the activity of all three classes of nuclear
RNA polymerases (Cavanaugh et al, 1995; White et al, 1996).
Several viral oncoproteins, including the HPV E7 oncoprotein
(Dyson et al, 1989), bind only to the underphosphorylated form of
pRB. By doing so, they presumably promote cells to proceed
through the cell cycle by blocking pRB's normal functions.
Indeed, the HPV E7 protein as well as the simian virus 40 large
tumour antigen can dissociate the E2F-pRB complex, and this
protein complex is shown to be absent in various human cervical
carcinoma cell lines that express the HPV E7 oncoprotein
(Chellappan et al, 1992).
Regulation ofDNA precursor metabolism plays a central role in
connection with the suppression of cell growth under hypoxic
conditions. It appears that reduced progression through S-phase is
halted or inhibited under moderate hypoxia (greater than approxi-
mately 100 p.p.m. oxygen) due to reduced de novo synthesis of
pyrimidine deoxynucleotides (Loffler, 1992; Amellem et al,
1994). Suppression of the enzymatic activity of two enzymes,
which both depend on the presence of molecular oxygen,
dihydroorotate dehydrogenase and ribonucleotide reductase, is
presumably responsible for the reduced pyrimidine deoxynucleo-
tide pools observed during hypoxia (Loffler et al, 1983). In some
cells, addition ofpyrimidine deoxynucleosides (such as deoxycyti-
dine) under moderate hypoxia is used by the salvage pathway to
restore the dCTP/dTTP pools and thus cell cycle progression
(Amellem et al, 1994).
In the present paper, we investigate the role of the cell cycle
checkpoint network (i.e. pRB) vs the biosynthetic machinery (i.e.
pyrimidine metabolism), which are both potentially important
components in the regulation of cell cycle progression under
hypoxic conditions. We demonstrate that addition of pyrimidine
deoxynucleosides to cells exposed to moderate hypoxia do not
overcome the inhibition of DNA synthesis in cells with functional
pRB, in contrast to cells in which pRB is non-functional. This
indicates that inhibition of cell cycle progression under hypoxic
conditions is primarily regulated through the cell cycle checkpoint
network, i.e. pRB, and secondly at the biosynthetic level through
pyrimidine metabolism.
MATERIALS AND METHODS
Cell cultures
The human breast cancer cell line T-47D (Keydar et al, 1979) was
grown as a monolayer culture in RPMI-1640 medium (Gibco),
supplemented with 10% fetal calf serum (Gibco), 2 mM L-gluta-
mine (Gibco), 200 units l-1 insulin, and 1% penicillin/streptomycin
(Gibco), at 37°C in air containing 5% carbon dioxide. The
doubling time for an exponentially growing population of T-47D
cells was 37.2 ±2 h (Stokke et al, 1993). The human osteosarcoma
cell line SAOS-2 was grown as monolayer culture in RPMI-1640
medium (Gibco), supplemented with 10% fetal calfserum (Gibco),
2 mM L-glutamine (Gibco), and 1% penicillin/streptomycin
(Gibco), at 37°C in air containing 5% carbon dioxide. The human
cervical carcinoma cell line NHIK 3025 (Nordbye and Oftebro,
1969; Oftebro and Nordbye, 1969) was grown as a monolayer
culture in E2a medium (Puck et al, 1957) containing 20% human
serum (prepared in the laboratory), 10% horse serum (Gibco), 2
mM L-glutamine (Gibco), and 1% penicillin/streptomycin (Gibco),
at 37°C in air supplied with 5% carbon dioxide. NHIK 3025 cells
contain integrated HPV18 and express the HPV18 E7 oncoprotein
(Figure 4). The median cell cycle duration for NHIK 3025 cells
was 16.5 h (Amellem et al, 1994). All cell lines were kept in
exponential growth by reculturing three times a week.
Hypoxic cell cultures
The cells were seeded in 70-mm glass dishes (Anumbra, Czech
Republic) 1 day before the experiment and incubated in a carbon
dioxide incubator. At the appropriate time, the glass dishes were
brought from the carbon dioxide incubator into a walk-in incu-
bator room at 37°C. The medium content in each dish was reduced
from 10 to 3.5 ml and placed without lids in a stainless steel
chamber. Deoxygenation took place by continuous flushing of the
chamber with a gas mixture (Hydro Gas, Norway) of highly puri-
fied 97% nitrogen, 3% carbon dioxide, and 100 or 1300 p.p.m.
oxygen at 37°C, as described previously (L0vhaug et al, 1977).
The hypoxic atmosphere in the chamber was established about
12 min after the start of flushing. Untreated control populations
were kept in the carbon dioxide incubator during the experiment.
Extraction, fixation and staining for measurement of
nuclear-bound pRB and DNA content
All steps were carried out at 0°C. Harvested cells were washed
once in phosphate-buffered saline (PBS). Detergent-extracted
fixed cells were prepared by resuspending cells in 1.5 ml of low-
salt detergent buffer [10 mm sodium chloride, 5 mm magnesium
chloride, 0.1 mm phenylmethylsulphonyl fluoride, 0.1% Nonidet
P-40, 10 mm phosphate buffer (pH 7.4)]. After 15 min, the
extracted cells, which will be termed nuclei, were added to 0.5 ml
of 4% paraformaldehyde under vortexing. Nuclei were fixed for
1 h, and then washed twice in washing buffer [10 mm Tris, 0.15
mm sodium chloride, 2 mm magnesium chloride and 0.1% Triton
X-100 (pH 7.4)]. pRB was detected using the PMG3-245 mono-
clonal antibody (Pharmingen), which recognized both the under-
and hyperphosphorylated forms of the protein (Mittnacht and
Weinberg, 1991; Dowdy et al, 1993; Stokke et al, 1993). pRB
staining was accomplished by a three-layer procedure. Nuclei
were resuspended in 25 gl of 5% non-fat dry milk dissolved in
washing buffer. Ten minutes later the anti-pRB monoclonal anti-
body was added to a final concentration of 2 gg ml-' in a total of
50gl. The control samples received PBS and no primary antibody
(data not shown). After a 30-min incubation, the nuclei were
washed twice and incubated for 30 min in 100 pl of biotinylated
horse anti-mouse IgG1 (HAM) (Vector) diluted 1:50 in washing
buffer. The nuclei were washed twice and then incubated for
30 min in 100 gl ofstreptavidin-FITC (Amersham) diluted 1:50 in
washing buffer. The antibodies and the streptavidin-FITC were
present in saturating amounts. After washing the nuclei twice, they
were resuspended in 2 gg ml-' Hoechst 33258 for additional
staining ofDNA.
Fixation and staining for BrdUrd and DNA content
Pulse-chase labelling with bromodeoxyuridine (BrdUrd) was used
to record DNA synthesis in cells under hypoxic conditions. Cells
were incubated with medium supplemented with 10giM BrdUrd for
30 min and then washed twice in Hanks' salt solution and twice in
medium before the hypoxic treatment. Harvested cells were washed
once with PBS, fixed in 70% methanol and stored at -20'C. Fixed
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Figure 1 Effect of moderate hypoxia on the phosphorylation state of pRB. T-
47D cells were exposed to aerobic (lane 1) or moderately hypoxic conditions
(1300 p.p.m. oxygen) (lanes 2 and 3) for 20 h. Cell populations were
supplemented with medium containing 0.1 mm deoxycytidine (dC) during
hypoxia (lane 3). Whole-cell extracts were prepared from T-47D cells. An
equal amount of whole-cell protein extracts was loaded for each lane and
separated by PAGE (8%). Western blot analysis was performed as described
in Materials and methods. The blot was hybridized with anti-human pRB
monoclonal antibody (Pharmingen, G3-245). One representative of two
reproducible experiments is shown
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cells were washed with PBS, resuspended in 2 ml of0.2% pepsin in
2 N hydrochloric acid, and incubated for 1 h at room temperature.
From here all steps were performed at 0°C. The cells were washed
three times in PBS, and a three-layer procedure for staining BrdUrd
was used. Cells were resuspended in 50g1 ofanti-BrdUrd antibody
(Becton-Dickinson) diluted 1:10 in PBS containing 0.5% Tween 20
and 0.5% bovine serum albumin (BSA). After a 30 min incubation,
cells were washed three times in PBS, and incubated with 50gl of
HAMs diluted 1:50 in PBS containing 0.5% Tween 20 and 0.5%
BSA for 30 min. Thecells were then washed three times in PBS and
incubated with 50gl of streptavidin-FITC diluted 1:50 in PBS
containing 0.5% Tween 20and0.5% BSA for 30 min. Afterthe cells
were washed, they were resuspended in 2gg ml-1 Hoechst 33258 for
additional staining ofDNA.
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Figure 2 The cell cycle distribution, and the fraction of pRB+ nuclei, of exponentially growing cells under aerobic (A-G) or moderately hypoxic conditions
(H-O). T-47D cells were exposed to moderately hypoxic conditions (1300 p.p.m. oxygen) for 20 h supplemented with plain medium (H-K) or medium containing
0.1 mM deoxycytidine (dC) (L-0). Control cells were labelled with BrdUrd for 30 min under aerobic conditions, washed, and either fixed immediately (A-C) or
20 h after labelling (E-G). Cells were treated with low salt detergent buffer for 15 min to isolate nuclei before addition of anti-pRB monoclonal antibody
(Pharmingen, PMG 3-245) as described under Materials and methods (D, H, L). The fraction of pRB+ nuclei is indicated by the windows shown in histogram D,
H and L. pRB (D, H, L) and BrdUrd-labelled cells (A, E, I, M) were FITC-stained with a three-layer procedure. DNA were stained with Hoechst 33258 and
measured by flow cytometry as described in Materials and methods (A-O). The histograms in each figure (A-O) were generated from list-mode files by gating
as described in Materials and methods. The various histograms show pRB content vs (abscissa) DNA content (ordinate) (D, H, L), BrdUrd content (abscissa) vs
DNA content (ordinate) (A, E, I, M), and the single parameter DNA histograms from the BrdUrd- (B, F, J, N) and BrdUrd+ (C, G, K, 0) fractions as indicated by
the windows shown in histogram A, E, I, and M
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Figure 3 The fraction of cells in G1, S and G2 exposed to moderate hypoxia
and the corresponding fraction of pRB+ nuclei in the various cell cycle
phases. T-47D cells were exposed to aerobic or moderately hypoxic
conditions (1300 p.p.m. oxygen) for 20 h. Some cell populations were
supplemented with medium containing 0.1 mm deoxycytidine (dC) during
moderate hypoxia. The data were generated from the flow cytometric
histograms shown in Figure 2. A shows the fraction of G,-nuclei that are
pRB+ (0) and the fraction of cells in G1 (@).B shows the fraction of S nuclei
that are pRB+ (0) and the fraction of cells in S (-). C shows the fraction of
G2+M nuclei that are pRB+ (A ) and the fraction of cells in G2+M (A)
Flow cytometry
Stained cells or nuclei were measured in a FACStarPIus flow
cytometer (Becton-Dickinson) equipped with two argon lasers
(Spectra Physics) tuned to 488 nm and UV respectively. The
following parameters were measured: forward light scatter (FSC),
side scatter (SSC), FITC fluorescence intensity (pRB or BrdUrd),
integrated Hoechst 33258 intensity (DNA content), Hoechst 33258
fluorescence pulse height, and Hoechst 33258 fluorescence pulse
width. The FITC fluorescence intensity voltage (amplification)
was kept constant at 500 V in all experiments. The data were gated
on FSC vs SSC and Hoechst 33258 fluorescence pulse height vs
pulse width to exclude dead cells and aggregates of cells respec-
tively (not shown in the figures).
Estimation of kinetic parameters
The fraction ofpRB+ (denoted bound pRB, which means that pRB
is under-phosphorylated) in nuclei or cells with incorporated
BrdUrd (BrdUrd+ cells) was obtained by measuring the relative
numbers of nuclei or cells in the peaks with high FITC fluores-
cence intensity values. The cycle distribution was estimated by
computer simulation of the DNA distribution using the computer
program Modfit.
Sodium dodecyl sulphate (SDS)-polyacrylamide gel
electrophoresis and Western blotting
Forprotein analysis bypolyacrylamide gel electrophoresis (PAGE),
cells attached to glass dishes were washed once in ice-cold
PBS and then scraped and dissolved in 100gl of sample buffer
(Laemmli, 1970), containing 0.1 mm phenylmethylsulphonyl
fluoride, 25 jg ml- aprotinin, 24giM leupeptin and 100 nM okadaic
acid on ice. The whole-cell extracts were heated in boiling water
for 5 min. Equal amounts of whole-cell protein extracts were
loaded in each lane and separated by electrophoresis in 8%
discontinuous SDS-polyacrylamide gels (Laemmli, 1970), with a
4% stacking gel. Proteins were transferred onto nitrocellulose
membrane (NitroPure, MSI) using an electroblotter in 25 mm Tris-
HCl (pH 8.3), 150 mm glycine and 15% methanol. The membranes
were then immunolabelled with 2 ,ug ml-' anti-human monoclonal
antibody against pRB (Pharmingen, PMG3-245), pl6INK4a
(Pharmingen, G175-405) or p2lwAFI (Oncogene Science, EAIO),
and detected with Amersham ECL Western Detection kit
(Amersham). The manufacturer's protocol was slightly modified
with the additions of5% non-fat dry milk and 0.02% Triton X-100
added to the staining solution.
Reverse transcriptase polymerase chain reaction
(RT-PCR) analysis
RT-PCR was used to check for appropriate expression of the
HPV18 E7 gene in NHIK 3025 cells. mRNA was isolated from
cell lysates and subjected to a second cycle of purification before
applying RT-PCR (Boehringer Mannheim mRNA isolation kit).
Reverse transcription with random hexamers was performed on
0.05 jig of mRNA with 1.25 U reverse transcriptase in a 50-gl
reaction (Perkin Elmer RNA PCR kit), followed by PCR reactions
using 2.5 U Taq DNA polymerase (Boehringer Mannheim) in a
SO-,ul reaction. The upper primer, plE7 (CCG AGC ACG ACA
GGA ACG ACT), from position 533 to 553, and the lower primer,
p2E7 (TCG TTT TCT TCC TCT GAG TCG CTT), from position
682 to 705, were used as described previously (Hagmar et al,
1992). Both these primers were located within the E7 gene.
Another lower primer, p3E4 (GGA ATA CGG TGA GGG GGT
GTG), from position 3483 to 3503 within the E4 gene was used
with the same upper primer (plE7) in separate reactions (see
Figure 4A). The reverse transcriptase was omitted in the control
reactions to confirm the absence of DNA contamination in the
reaction tubes. The PCR products were analysed on 3% NuSieve
GTG agarose gels (FCM) and stained with ethidium bromide.
RESULTS
Addition of pyrimidine deoxynucleosides do not
overcome the inhibition of DNA synthesis induced by
moderate hypoxia in cells expressing wild-type pRB
In T-47D cells grown under aerobic conditions, the pRB retained
in the nuclei was predominantly in its phosphorylated form
(Figure 1, lane 1), which is confirmed by the high fraction ofpRB-
nuclei measured by flow cytometry (Figure 2D). However, a shift
in the phosphorylation state of pRB to its under-phosphorylated
form is observed after 20 h growth under moderately hypoxic
conditions (1300 p.p.m. oxygen) (Figure 1, lane 2). The dephos-
phorylation of pRB is not affected by the absence or presence of
0.1 mM dC underhypoxic conditions (Figure 1, lane 3).
To relate the effect variations ofnuclear binding ofpRB (pRB+)
during moderate hypoxia to the cell cycle stage, the fraction of
pRB+ nuclei were generated from flow cytometric list mode data
for nuclei derived from cells in G I S and G2 phases of the cell
cycle. For aerobic (i.e. control) T-47D cells, pRB+ nuclei were
found in the G, phase only (Figure 2D). A dramatic change in the
fraction of pRB+ nuclei was observed after 20 h exposure to
moderate hypoxia (1300 p.p.m. oxygen) (Figure 2 h). The most
pronounced increase in the fraction ofpRB+ nuclei (dephosphoryl-
ation ofpRB) occurred for T-47D cells in S and G2, whereas only
a modest increase was observed in the fraction of pRB+ nuclei in
G, (Figure 2 h).
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Figure 4 RT-PCR amplification of HPV18 gene expression. (A) Diagram of
HPV18 region analysed. (B) mRNA was isolated from NHIK 3025 (lanes
2-4), HeLa S3 (lanes 5-7) and MCF-7 cells (lane 8). Lane 1 represents
100 bp DNA ladder standard (Pharmacia). The same upper primer, p1 E7
(bp 533-553), was included in all reactions (lanes 2-8). Two different lower
primers were used. The p2E7 lower primer (bp 618-705) was used in the
reactions shown in lanes 3, 4, 6, 7 and 8. The p3E4 lower primer
(bp 3483-3503) is used in the reactions shown in lanes 2 and 5. The yield is
two different transcripts, E7 (lanes 2 and 5) and E7AE4 (lanes 3 and 6), of
173 and 430 bp respectively. Reverse transcriptase was excluded from the
reactions shown in lanes 4 and 7. MCF-7 cells were included as a negative
control (lane 8) and HeLa S3 cells (lanes 5-7) as a positive control as the
latter cells contain HPV1 8 (Boshart et al, 1984). Agarose gel electrophoresis
of DNA from the RT-PCR amplification of the HPV1 8 probes was visualized
by staining with ethidium bromide
In a previous study, we showed that addition of deoxycytidine
during moderate hypoxia in NHIK 3025 cells reversed the cell
cycle-inhibitory effect of hypoxia (Amellem et al, 1994). In the
present study, we therefore added 0.1 mm deoxycytidine to see if
this treatment could reverse the hypoxia-induced arrest that was
related to the rebinding (dephosphorylation) of pRB to nuclear
structures in cells in S-phase. The data show, however, that neither
the increase in the fraction of pRB+ nuclei nor the cell cycle
progression itself are affected by the addition of deoxycytidine
under moderate hypoxia (Figure 2L). These data support our
observation made by Western blotting (Figure 1, lane 3), indicating
that pRB becomes dephosphorylated under moderate hypoxia both
in the absence and in the presence of pyrimidine deoxynucleo-
sides.
To visualize the magnitude of the changes in the fraction of
pRB+ nuclei in various cell cycle phases of the T-47D cells as
presented in Figure 2D, H, and L, the fraction of pRB+ nuclei was
analysed for each cell cycle phase, and the results are shown in
Figure 3. The fraction of pRB+ nuclei with S and G2 DNA content
increased from 0.05 to > 0.90 during 20 h exposure to moderate
hypoxia (Figure 3B and 3C). In comparison, the increase in the
fraction of pRB+ nuclei with G, DNA content taking place
during the same treatment was less pronounced (from 0.37 to 0.76,
Figure 3A).
DNA-replicating cells incorporate BrdUrd into their DNA
(BrdUrd+), and are easily distinguishable from non-BrdUrd-labelled
cells (BrdUrd-) (Figure 2A). In a pulse-chase experiment, exponen-
tially growing T-47D cells were labelled with BrdUrd before the
hypoxic treatment. The fraction of BrdUrd+ with S-phase DNA
content remained unchanged if one compares the situation immedi-
ately after the pulse and before hypoxia (i.e. aerobic conditions,
Figure 2A and 2C) and after 20 h exposure to 1300 p.p.m. oxygen
(Figure 21 and K), which means that no T-47D cells have left S-
phase under 20 h of moderately hypoxic conditions. In contrast, the
fraction of BrdUrd+ with S-phase DNA content reached GI of the
subsequent cell cycle if one compares the situation immediately
after the pulse (Figure 2A and C) with the situation after 20 h
exposure to aerobic conditions (Figure 2E and G). The presence of
deoxycytidine under moderate hypoxia had no effect on the fraction
of BrdUrd+ cells in S-phase (Figure 2M and 0), indicating that the
addition of pyrimidine deoxynucleosides did not abolish the
hypoxia-induced S-phase arrest. It was also evident from the frac-
tion of BrdUrd- cells present, that, in contrast to the situation seen
under aerobic conditions (Figure 2E and F), no T-47D cells enter S-
phase under these hypoxic conditions (Figure 2J and N). Only in the
G2 compartment was a small decrease observed in the fraction of
BrdUrd- cells after moderate hypoxia (compare Figure 2A with I or
M), showing that cell division takes place under moderate hypoxia
in cells with functional pRB.
Addition of pyrimidine deoxynucleosides overcome the
inhibition of DNA synthesis induced by moderate
hypoxia in cells expressing the HPV18 E7 oncoprotein
The cervical carcinoma cell line, NHIK 3025, does not express
pRB, as shown by Western blotting (Stokke et al, 1993) and flow
cytometry (data not shown). RT-PCR was used to identify the
expression of the HPV18 E7 gene in NHIK 3025 cells (Figure 4B,
lanes 2 and 3). One upper primer in combination with either one of
two lower primers from different parts ofthe HPV18 genome yield
two products, confirming the expression of the E7 and the E7AE4
type transcripts (173 and 430 bp respectively). The RT-PCR was
performed using one negative control (MCF-7 cells) (Figure 4b,
lane 8), one positive HPV18 control from HeLa S3 cells (Figure
4b, lanes 5 and 6), and two reaction controls in which reverse tran-
scriptase was excluded to ensure the absence of DNA contamina-
tion in the reaction tubes (Figure 4B, lanes 4 and 7). The HPV18
E7 oncoprotein has the ability to bind and thus inactivate pRB
(Tommasino and Crawford, 1995). To induce a similar degree of
cell cycle inhibition in NHIK 3025 cells as induced by 1300 p.p.m.
oxygen in T-47D cells, we had to reduce the concentration to only
100 p.p.m. oxygen.
In a pulse-chase experiment, exponentially growing NHIK 3025
cells were labelled with BrdUrd before the hypoxic treatment. More
than half the population of cells, initially labelled with BrdUrd
(BrdUrd+) (Figure SC), remained in S-phase after 18h exposure to
100 p.p.m. oxygen (compare Figure SC with I), whereas the rest ofthe
labelled cells reached either G2+M (18%) or divided and reached G,
(29%) ofthe subsequent cell cycle. It was also evident that only a few
ofthe BrdUrd-NHIK 3025 cells, initially in G,, entered S-phase under
these hypoxic conditions (compare Figure SB with H). Compared with
the growth of control cells (i.e. under aerobic conditions) (Figure
5D-F), the hypoxic cells (Figure SG-I), thus, reduced the rate of cell
cycle progression significantly. However, the addition of 0.1 mM
deoxycytidine under moderate hypoxia increased the rate ofcell cycle
progression significantly (Figure 2J-L). About 88% of the cells
initially labelled with BrdUrd progressed out of S-phase in the pres-
ence of 0.1 mM deoxycytidine under moderately hypoxic conditions
(compareFigure5AwithJ orFigureSC withL). This indicates thatthe
addition ofpyrimidine deoxynucleosides abolishes the S-phase arrest
induced by moderate hypoxia (compare Figure SG with J orFigure SI
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Figure 5 Flow cytometric histograms of BrdUrd content vs DNA content, and the cell cycle distribution of BrdUrd- or BrdUrd+, respectively, of NHIK 3025 cells.
Cells were exposed to aerobic (A-F) or moderately hypoxic conditions (100 p.p.m. oxygen) (G-L) for 18 h. The cells were labelled with BrdUrd for 30 min under
aerobic conditions, washed and fixed either immediately (A-C), 18 h after exposure to aerobic conditions ( D-F) or 18 h after exposure to moderately hypoxic
conditions (G-L). Cell populations were supplemented with medium containing 0.1 mm deoxycytidine (dC) during hypoxia (J-L). BrdUrd-labelled cells were
FITC-stained with a three-layer procedure, whereas DNA were stained with Hoechst 33258 and measured by flow cytometry as described in Materials and
methods. The histograms show BrdUrd content (abscissa) vs DNA content (ordinate) (A, D, G, J), and the DNA histograms from the BrdUrd- (B, E, H, K) and
BrdUrd+ (C, F, I, L) fractions as indicated by the windows shown in histograms A, D, G, and J
withL) incellsexpressingtheHPV18 E7oncoprotein. The presenceof
deoxycytidine also stimulated BrdUrd- cells in G, to progress further
into S and G2+M phase under moderately hypoxic conditions
(compare Figure 5G with J orFigure 5H with K).
Addition of pyrimidine deoxynucleosides overcome the
inhibition of DNA synthesis induced by moderate
hypoxia in cells which lack pRB expression
To further determine whether the hypoxia-induced cell cycle arrest
in pRB-deficient cells is due to lack of pyrimidine deoxynucleo-
sides, we exposed SAOS-2 cells to 1300 p.p.m. oxygen for 18 h in
the absence or presence of 0.1 mM deoxycytidine (Figure 6).
SAOS-2 cells lack functional pRB (Ewen et al, 1993).
Exponentially growing SAOS-2 cells were pulse-labelled with
BrdUrd before the hypoxic treatment. We found that more than
half the population of cells, initially labelled with BrdUrd
(BrdUrd+) (Figure 6A), remained in S-phase after 20 h exposure to
1300 p.p.m. oxygen (Figure 6C). However, most of these BrdUrd+
cells arrested in S-phase under moderate hypoxia were able to
complete DNA synthesis in the presence of0.1 mm deoxycytidine
(compare Figure 6C with D, Figure 7D). Even in the presence of
deoxycytidine the rate of cell cycle progression was still reduced
under moderately hypoxic compared with under aerobic condi-
tions (compare Figure 6B with D). Some ofthe cells initially inGI
(BrdUrd-) entered S-phase under these hypoxic conditions
(compare Figure 6A with C). These results support the experiment
presented in Figure 5, suggesting that in the absence of functional
pRB inhibition of de novo synthesis of pyrimidine deoxy-
nucleotides is the main mechanism responsible for the hypoxia-
induced arrest in S-phase.
Analysis of the DNA distribution in the BrdUrd- and the
BrdUrd+ fraction in both T-47D (Figure 2), NHIK 3025 cells
(Figure 5) and SAOS-2 cells (Figure 6) are presented in Figure 7.
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Figure 6 Flow cytometric contour plots of BrdUrd content vs DNA content of
SAOS-2 cells. Cells were exposed to aerobic (A and B) or moderately
hypoxic conditions (1300 p.p.m. oxygen) (C and D) for 20 h. The cells were
labelled with BrdUrd for 30 min under aerobic conditions, washed and fixed
either immediately (A), 20 h after exposure to aerobic conditions (B) or 20 h
after exposure to moderately hypoxic conditions (C and D). Cell populations
were supplemented with medium containing 0.1 mm deoxycytidine (dC)
during hypoxia (D). BrdUrd-labelled cells were FITC-stained with a three-layer
procedure, whereas DNA were stained with Hoechst 33258 and measured by
flow cytometry as described in Materials and methods.
Cdk inhibitors are not induced in p53-deficient cells
under hypoxic conditions
We next asked whether this hypoxia-induced cell cycle arrest could
be due to activation of cdk inhibitory proteins. However, pl6INK4a
was not detected by Western blotting in T-47D cells whether the
cells were cultured under aerobic ormoderately hypoxic conditions
(Figure 8, lanes 3 and 4 respectively). In contrast, pRB-deficient
NHIK 3025 cells expressed high levels of pl6INK4a under both
aerobic conditions and after 20 h exposure to moderately hypoxic
conditions (Figure 8, lanes 1 and 2 respectively).
As T-47D cells express mutated p53 (Bartek et al, 1990), and the
wild-type p53 functions is abrogated by the presence ofHPV E6 in
NHIK 3025 cells, the induction ofp2lwAFlcIPIl must occur indepen-
dently ofp53. Both NHIK 3025 and T-47D cells express low levels
of p2lWAFI/CIP1 under aerobic conditions (Figure 8, lanes 1 and 3
respectively). However, p2lWAF1/cIP1 decreased below the detection
level in both these cell types after exposure to moderately hypoxic
conditions for 20 h (Figure 8, lanes 2 and 4 respectively).
DISCUSSION
Cell cycle regulation during moderate hypoxia in cells
with functional or non-functional pRB
The results presented here demonstrate that pRB is dephosphoryl-
ated (Figure 1) and re-bound (here termed pRB+) (Figure 2H and
L) in the nucleus in T-47D cells under moderate hypoxia
(1300 p.p.m. oxygen). This marked change in the state of pRB
phosphorylation towards a more under-phosphorylated form under
moderately hypoxic conditions is most pronounced in the nucleus
ofcells in the S and G2 phases ofthe cell cycle. In more than 90%
of these cells, pRB is dephosphorylated and re-bound in the
nucleus during a 20 h treatment with moderate hypoxia, which is
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Figure 7 The fraction of BrdUrd- cells and BrdUrd+ cells, respectively, in G1,
S and G2+M after exposure to moderate hypoxia. T-47D cells (0) and SAOS-
2 cells (O) were exposed to aerobic or moderately hypoxic conditions
(1300 p.p.m. oxygen) for 20 h, whereas NHIK 3025 cells (0) were exposed to
aerobic or moderately hypoxic conditions (100 p.p.m. oxygen) for 18 h, both in
the absence or in the presence of medium supplemented with 0.1 mm dC
under moderately hypoxic conditions. The cells were labelled with BrdUrd for
30 min as described in Materials and methods. The data were generated
from the flow cytometric histograms shown in Figures 2, 5 and 6. The fraction
of BrdUrd+ cells are shown in B (Gl phase DNA content), D (S-phase DNA
content) and F (G2+M phase DNA content). The fraction of BrdUrd- cells is
shown in A(Gl phase DNA content), C (S-phase DNA content) and E (G2+M
phase DNA content)
opposite to the situation under aerobic conditions, in which only a
few per cent ofcells in S and G2 are pRB+. No T-47D cells entered
S-phase, and noprogression through S-phase was observed, during
the 20 h exposure to 1300 p.p.m. oxygen (Figure 2). The slow
dephosphorylation of pRB, as observed under extremely hypoxic
conditions (Amellem et al, 1996), indicates that the immediate
arrest is due to mechanisms other than pRB. The slow dephospho-
rylation of pRB, however, can explain why cells that are in G2 at
the onset of hypoxia complete the cell cycle and enter GI of the
next cell cycle during hypoxia (Figure 2). Hypoxic stress, which
becomes increasingly toxic with time, particularly to cells in S-
phase (Merz and Schneider, 1983; Spiro et al, 1984; Amellem and
Pettersen, 1991a), may activate pRB to prevent harmful effects
that could follow from continued DNA replication during hypoxia.
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Figure 8 Effect of moderate hypoxia on the pl6INK4a and p21WAF1/CiP1 protein
level. NHIK 3025 and T-47D cells were exposed to aerobic (lanes 1 and 3
respectively) or moderately hypoxic conditions (1300 p.p.m. oxygen) (lanes 2
and 4 respectively) for 20 h. The samples were prepared from whole-cell
lysates. An equal amount of protein was loaded for each lane and separated
by PAGE (8%). The relative p1 64NKa and p21WAFlCIPi protein level was
determined by Western blot analysis as described in Materials and methods.
The blots were hybridized with anti-human p16INK4a monoclonal antibody
(Pharmingen, G175-405) or anti-human p21WAF1 monoclonal antibody
(Oncogene Science, EA10). One representative of three reproducible
experiments is shown
Several lines of evidence have linked the under-phosphorylated
form of pRB to its role as an inhibitor of cell cycle progression
through G, (reviewed by Weinberg, 1995). It is, therefore,
tempting to suggest that dephosphorylation of pRB under
moderate hypoxia is also responsible for the hypoxia-induced cell
cycle arrest in S-phase. The hypoxia-induced dephosphorylation
ofpRB could be due to either a prevention ofa kinase or an activa-
tion of a phosphatase or both. The growth-suppressing activity of
pRB is down-regulated by various cdks (i.e. cdk4/6-cyclin D,
cdk2-cyclin E and cdk2-cyclin A) whose kinase activity is nega-
tively regulated by cdk inhibitors ofthe p16 and p21 families. As
p21WAF1/CIPI, and the related p27'P1, can associate with multiple
cyclin-cdk complexes, associated withG, and S-phases (reviewed
by Sherr and Roberts, 1995), it is most likely that they can exert
controls at multiple points in the cell cycle. A possible explanation
to the dephosphorylation of pRB during hypoxia could, therefore,
be that it is mediated by p53-dependent activation ofp211l/C 1.
However, the p53 gene is mutated in T-47D cells (Nigro et al,
1989), and the p53 protein level does not change in response to
neither hypoxia (Amellem et al, 1997) nor irradiation (data not
shown), indicating that p53 is not involved in the possible inhibi-
tion of pRB kinases during hypoxia. This supports the view that
dephosphorylation of pRB is due to activation of a pRB phos-
phatase in the absence of constitutive pRB kinase activity. This
view is further supported by our previous results, showing that
dephosphorylation of pRB under extremely hypoxic conditions is
independent of the p53 gene status (Amellem et al, 1996). It has
been suggested that pRB-mediated G, arrest, independent ofp53,
could be achieved through activation of a pRB phosphatase (Dou
et al, 1995; An and Dou, 1996). On the otherhand, p2lWAFl/CIPl can
also be activated by p53-independent mechanisms (Macleod et al,
1995; Russo et al, 1995). Our results show that both T-47D and
NHIK 3025 cells express low levels of p2lwAFIl/cPl under aerobic
conditions. T-47D cells have previously been shown to express
barely detectable levels ofp21WAF1/cIPl mRNA (Sheikh et al, 1994).
However, p21wAFI/CIP1 was not detectable by Western blot analysis
under moderately hypoxic conditions in both these cell types. In
addition, pl6INK4a was not detectable in T-47D cells, whether
the cells were cultured under aerobic or moderately hypoxic
conditions. Furthermore, two other members of the p16 family,
p15INK4b and p18INK4c, are found to be mutated in T-47D cells
(Zariwala et al, 1996). Taken together, these data suggest that
neither members of the p16 family nor p21WAF1/CIP1 are involved
in the hypoxia-induced cell cycle arrest in p53-deficient T-47D
cells. The observed dephosphorylation of pRB under moderate
hypoxia did not depend on the activation of cdk inhibitors,
supporting the suggestion above that dephosphorylation is due
to activation of a pRB phosphatase. Furthermore, hypoxia has
been shown to induce p21WAF1/CIP1, but only in a wild-type p53-
dependent manner (Graeber et al, 1994). In general, the p53-
dependent expression of p21 WAFI/CIPi has mainly been associated
with the induction of cell cycle arrest (reviewed by Sherr and
Roberts, 1995). However, recent studies have suggested that the
role of p53 under hypoxic conditions is not associated with cell
cycle arrest (Graeber et al, 1994), but merely with the induction
of apoptosis (Graeber et al, 1996; Amellem et al, 1997). Thus,
the function of p21WAFl/cIPl under hypoxic conditions remains
unknown.
In contrast to T-47D cells, the human cervical carcinoma NHIK
3025 cells express the HPV18 E7 oncoprotein (Figure 4), known
to bind pRB and thereby inhibit its normal function. We were
unable to detect any pRB in NHIK 3025 cells as measured by flow
cytometry (data not shown) and Western blotting (Stokke et al,
1993). However, this pRB-deficient cell line express high levels of
pl6INK4a under both aerobic and hypoxic conditions. A high level
ofp16lNK4a has been shown previously in other cervical carcinoma
cell lines (Parry et al, 1995). Overexpression ofpl6INK4a has been
reported to prevent proliferation in pRB-functional cells, but is
ineffective in pRB-deficient cells (Guan et al, 1994). Therefore, in
NHIK 3025 cells lacking functional pRB, the inhibitory function
ofpl6INK4a may not be manifested.
The oxygen sensitivity regarding cell proliferation is rather
different in T-47D cells compared with NHIK 3025 cells. No T-
47D cells inGI seem to enter S-phase during the 20-h exposure to
1300 p.p.m. oxygen, despite the fact that approximately 25% of
the GI cells are still pRB-. This could indicate that mechanisms
other than pRB, such as the oxygen-dependent restriction in GI
(Amellem et al, 1994), are active in these cells, even under
moderate hypoxia, and prevent them from leaving GI. This is in
contrast to the situation in NHIK 3025 cells where the oxygen
concentration has to be reduced below 20 p.p.m. to completely
inhibit entry into S-phase (Pettersen and Lindmo, 1983). Thus, in
the present experiments with NHIK 3025 we used 100 p.p.m.
oxygen in contrast to 1300 p.p.m. oxygen used on T-47D cells.
Still, NHIK 3025 cells are able to proliferate under such condi-
tions, although the rate ofprogression is highlyreduced (Figure 5).
Although the normal dNTP pools are in general sufficient for only
a few minutes of DNA synthesis (Reichard, 1988), some NHIK
3025 cells are still able to progress out ofS-phase and even further
into the next cell cycle (Figure 5). This indicates that the oxygen-
dependent DNA precursor metabolism continues to be active for a
few hours even at oxygen concentrations as low as 100 p.p.m.
before the NHIK 3025 cells become arrested.
The E7 oncoprotein has been shown to disrupt the interaction
between the transcription factor E2F and pRB, and this protein
complex is absent in various cervical carcinoma cell lines that
express E7 (Chellappan et al, 1992). This protein complex is
believed to result in the growth suppressive function that pRB
exerts in theearly parts ofG, (Bagchi etal, 1991; Helin et al, 1993;
Lees et al, 1993). E7 binds only to the under-phosphorylated form
ofpRB (Dyson et al, 1989), which is its functional form. By doing
so, E7 presumably promotes cells to proceed through the cell
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cycle. Indeed, expression of the E7 oncoprotein allows cell cycle
progression, both under hypoxic conditions (Figure 5) and after
DNA damage induced by irradiation (Hickman et al, 1994;
Slebos et al, 1994).
The role of pyrimidine metabolism in the regulation of
cell proliferation under moderate hypoxia in cells with
functional or non-functional pRB
Addition of deoxynucleosides to T-47D cells during exposure to
moderate hypoxia did not counteract the hypoxia-induced cell
cycle arrest in these cells (Figures 1 and 2). Similar lack of
response has also been found in other cell types with normal pRB
status, such as MCF-7 and Reh cells (data not shown). We can rule
out the possible explanation that hypoxia might have induced
some perturbation of the salvage pathway, as the thymidine
analogue BrdUrd was readily incorporated into DNA. Instead, it
is more likely that cell cycle inhibition in T-47D cells under
protracted moderate hypoxia is due to activation of pRB. This is
highly supported by our observation that hypoxia-induced cell
cycle arrest of NHIK 3025 cells (Figure 5) and SAOS-2 cells
(Figure 6), both lacking functional pRB, was abolished by addition
of pyrimidine deoxynucleosides (i.e. dC). It is also in accordance
with this explanation that the addition of exogenously added
deoxycytidine did not affect the phosphorylation state of pRB in
T-47D cells under moderate hypoxia (Figure 1), i.e. pRB also
remained dephosphorylated in the presence of excess amounts of
deoxynucleosides. pRB, thus, seems to over-rule the stimulatory
effect of addition of deoxynucleosides, and, therefore, may be the
main regulator of cell proliferation under moderate hypoxia. One
important aspect, here, is the slow kinetics regarding the hypoxia-
induced dephosphorylation of pRB (Amellem et al, 1996). This
implies that the immediate arrest observed under moderate
hypoxia in T-47D cells is mediated by some mechanisms other
than through the pRB pathway. One possible explanation is that
the oxygen-dependent catalytic activity of dihydroorotate de-
hydrogenase and/or ribonucleotide reductase in T-47D cells needs
higher concentrations of oxygen than the concentrations needed in
NHIK 3025 or SAOS-2 cells in order to be enzymaticaly func-
tional. However, this remains to be elucidated.
The suppressive effects of pRB is supposed to be mediated by
the underphosphorylated form of the protein (Buchkovich et al,
1989; DeCaprio et al, 1989; Mihara et al, 1989) by sequestering
the transcription factor E2FI-3 (Bagchi et al, 1991; Chellappan
et al, 1991). If, therefore, moderate hypoxia promotes rebinding of
pRB to E2F-1, we can have a simple explanation of how pRB
inhibit progression through S-phase during such hypoxia.
Recently, it has been demonstrated that genes encoding S-phase-
specific proteins are induced by E2F-1 [including both subunits of
ribonucleotide reductase (RI and R2), DNA polymerase o,
thymidylate synthase, proliferating cell nuclear antigen]
(DeGregori et al, 1995). In addition, E2F-1 has been shown to be a
prerequisite for the expression of genes implicated in growth
control (including cdc2, cyclin A, cyclin E, c-myc, B-myb, and the
E2F-1 gene itself) that have E2F-binding sites in their promoters
(reviewed by La Thangue, 1994). For example, cyclin A, which is
involved in the control of cell cycle progression through S-phase,
and at the entry into mitosis (Girard et al, 1991; Pagano et al,
1992), is reduced in hypoxia-arrested cells in S-phase (Ludlow et
al, 1993b). Another possibility that might explain the involvement
of pRB in hypoxia-induced growth arrest is the recent discovery
that pRB can inhibit cell proliferation through a more global regu-
lation of genes by repressing the transcription of all three classes
of nuclear RNA polymerases (Cavanaugh et al, 1995; White et al,
1996). Thus, from the present as well as previous results, it seems
that the hypoxia-induced cell cycle arrest is due to both a direct
inhibition of DNA synthesis (Loffler, 1992; Amellem et al, 1994)
and by activation of pRB (Ludlow et al, 1993b; this study), a key
member of the cell cycle checkpoint network, with E2F-1 as a
possible link between them.
Addition of pyrimidine deoxynucleosides to NHIK 3025 and
SAOS-2 cells partly reversed the S-phase arrest induced by
moderate hypoxia. However, normal rate of cell cycle progression
was not established, indicating that additional mechanisms regu-
late the rate of cell proliferation under such conditions. Similar
effects have been observed in Ehrlich ascites cells (Loffler, 1992).
Whether these cells contain wild-type pRB has, to our knowledge,
not been investigated. From our own data on NHIK 3025 and
SAOS-2 cells, we conclude as follows: in the absence of pRB
checkpoint control, the oxygen-dependent de novo synthesis of
pyrimidine deoxynucleotides seems to be the major limiting step
in the control of cell cycle progression through S-phase under
moderately hypoxic conditions.
It seems, from the present data, that the pRB status survey the
physiological growth conditions of the cell, and that it may, thus,
function as a stress indicator in the cell. This is, however, a slowly-
acting regulation and even in cells with functional pRB the imme-
diate arrest in S-phase after the onset of moderate hypoxia is
believed to be a consequence of blocking de novo synthesis of
pyrimidine deoxynucleotides due to inhibition of the two oxygen-
dependent enzymes, dihydroorotate dehydrogenase and ribo-
nucleotide reductase (Probst et al, 1989; Loffler, 1992; Amellem
et al, 1994; Brischwein et al, 1997). An additional explanation
proposed by Probst et al (1988) suggests that hypoxia inhibits the
initiation of new replicones, whereas DNA chain elongation and
termination proceed during hypoxia. They further demonstrated
that replicon initiation depends on one or several short-lived
proteins that are also formed under hypoxic conditions, suggesting
that hypoxic cells in S-phase are arrested in a state fully prepared
for entering DNA replication (Riedinger et al, 1992).
The dephosphorylated form of pRB seem to take over as the
main negative regulator about 4 h after the hypoxia-induced cell
cycle arrest (Amellem et al, 1996). Thus, the molecular down-
regulation of DNA replication under moderate hypoxia is gradu-
ally overridden by a member ofthe cell cycle checkpoint network,
pRB, which seems to serve as the main regulator of progression
through S-phase under moderately hypoxic conditions.
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ABBREVIATIONS
Ribonucleotide reductase [EC 1.17.4.1]; dihydroorotate dehydro-
genase [EC 1.3.3.1].; dNTP, deoxynucleotide triphosphate; dC,
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deoxycytidine; BrdUrd: bromodeoxyuridine; RT-PCR, reverse tran-
scriptase polymerase chain reaction; HPV, human papillomavirus.
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